Dawn Elizabeth De Vaul
About Dawn Elizabeth De Vaul
Dawn Elizabeth De Vaul is the Associate Director of Global Quality and Clinical Auditing QA at Bristol Myers Squibb, with over 24 years of experience in quality assurance and clinical auditing.
Title at Bristol Myers Squibb
Dawn Elizabeth De Vaul holds the position of Associate Director - Global Quality - Clinical Auditing QA at Bristol Myers Squibb. She began this role in August 2021. In her capacity, she is responsible for assessing responses, CAPAs, and effectiveness checks.
Previous Experience at Sanofi Genzyme
From 2006 to 2021, Dawn Elizabeth De Vaul was employed at Sanofi Genzyme as a Senior Manager and QA Auditor. During her 15-year tenure in Bridgewater, New Jersey, she gained substantial experience in clinical quality assurance.
Work Experience at Cordis and Novartis
Before joining Sanofi Genzyme, Dawn Elizabeth De Vaul served at Cordis as a Senior Auditor in Clinical Quality Assurance for 11 months from 2005 to 2006. Prior to that, she worked at Novartis as an International Auditor for 8 years, starting in 1997.
Education and Expertise
Dawn Elizabeth De Vaul earned her Bachelor of Science degree from Centenary University. She has extensive experience in auditing clinical-related activities, including investigator sites, clinical processes, vendor prequalification, and vendor services.
Background in Quality Assurance and Clinical Auditing
Dawn Elizabeth De Vaul has over 24 years of experience in quality assurance and clinical auditing. Her background includes roles at major pharmaceutical companies such as Sanofi Genzyme, Cordis, and Novartis, handling various capacities in quality assurance and auditing.